Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cost-Effectiveness Makes Medicare Bill; Research Agenda Due In 6 Months

Executive Summary

The Agency for Healthcare Research & Quality will develop a cost-effectiveness research agenda before the Medicare prescription drug benefit starts in 2006 under the Medicare Rx benefit conference agreement

You may also be interested in...



AHRQ Comparative Research Agenda Will Start With Rx Drugs

The Agency for Healthcare Research & Quality is recommending that its initial list of priorities for comparative effectiveness research should focus on prescription drugs

AHRQ Comparative Research Agenda Will Start With Rx Drugs

The Agency for Healthcare Research & Quality is recommending that its initial list of priorities for comparative effectiveness research should focus on prescription drugs

AHRQ Comparative Research Agenda Due June 8; HHS Priorities Will Be Key

The Agency for Healthcare Research & Quality plans to meet with senior HHS officials and other stakeholders to assist the agency in developing a cost-effectiveness research agenda by June 8

Related Content

UsernamePublicRestriction

Register

OM017301

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel